Phase 2 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who identify as either non-Hispanic Black or non-Hispanic White
- Men and women between 18 and 75 years old
- People whose blood pressure is in the normal range (top number below 130 and bottom number below 85)
- People with a low-density lipoprotein ("bad") cholesterol level below 150 mg/dL
- People with a blood sugar control measure (HbA1c) below 6.0%, which indicates no diabetes
Who may not be able to join:
- People with a rash, skin disease, or skin pigmentation condition such as psoriasis, eczema, or vitiligo
- People with known skin allergies to latex or adhesives
- People who have smoked or used any nicotine products in the past year
- People who use illegal or recreational drugs
- People with kidney disease
- People currently taking certain medications, including chloramphenicol, cholestyramine, seizure medications, methotrexate, nitrofurantoin, tetracycline, barbiturates, steroids, phenobarbital, phenytoin, orlistat, or pyrimethamine
- People taking any medications that could affect heart or blood vessel function (confirm with trial site)
- People who have been diagnosed with or are suspected to have a metabolic or heart/blood vessel condition
- People who are currently pregnant or breastfeeding
- People with a history of skin cancer or any other cancer
- People who have been diagnosed with or are suspected to have diabetes (HbA1c of 6.0% or higher)
- People with narcolepsy or any condition that affects the body's ability to regulate temperature
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 706-542-4378
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cutaneous microvascular responses to local heating; Flow-mediated dilation responses; Mitochondrial ROS production in peripheral blood mononuclear cells (PBMCs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.